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INTRODUCTION
Healthcare-associated infections (HAI) continue to be a 
major public health concern. A study published by ECDC 
has estimated that the impact of six healthcare-related in-
fections (pneumonia, urinary tract infections, surgical site 
infections, Clostridium difficile infections, neonatal sepsis 
and blood infections) is greater than that of diseases like 
flu, HIV/AIDS and tuberculosis. More than 2.5 million cas-
es of nosocomial infections occur in the European Union 
every year (Cassini et al., 2016).
Italian data are in line with the European average: 6.6% 
in Italy versus 6.0% in Europe (2.3-10.8%), although the 
frequency of some infections (such as intravascular cathe-
ter-associated infections) is higher than the European av-
erage (Ministry of Health of Italy, 2014). 
The most commonly isolated HAI causing microorgan-
isms in recent years were, in descending order: E. coli, 
Staphylococcus aureus, Enterococcus spp., Pseudomonas 
aeruginosa, Klebsiella spp., Coagulase-negative staphylo-
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cocci, Candida spp., C. difficile, Enterobacter spp., Proteus 
spp. and Acinetobacter spp. (ECDC, 2013); HAI are more 
frequent in high-risk patients, such as those admitted to 
intensive care units, burn victims, transplant candidates 
and infants. 
According to several European multicentre studies, about 
30% of intensive care patients in high-income countries 
have suffered an episode of HAI. (Vincent et al., 2009). In-
creased morbidity is observed in addition to the increase 
in mortality. Contraction of an infection during hospital-
ization, in general, determines a significant deterioration 
of the patient’s quality of life and an extension of their hos-
pital stay. It has been estimated that HAI alone are respon-
sible for about 16 million extra days in hospital each year 
in Europe (WHO, 2011). 
According to Italy’s National Surveillance of Intensive 
Care Infections (Report 2011-2012), the most commonly 
isolated germ was Klebsiella spp., followed by P. aerugino-
sa and S. aureus. A number of epidemiologically import-
ant HAI microorganisms are multidrug-resistant (MDR) 
germs that can spread rapidly and/or carry multiple resis-
tance to antibiotics, causing high mortality and possible 
nosocomial epidemics. The increased frequency of their 
isolation is due to the high use of antibiotics and the in-
crease in the use of invasive procedures, particularly in 
hospital departments with high-risk patients such as In-
tensive Care Units, Oncohematology, Transplant Units, 
but also in external clinics.
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SUMMARY
Healthcare-associated infections (HAI) continue to be a major public health concern. A number of epide-
miologically relevant HAI microorganisms are multidrug-resistant (MDR) germs that can spread rapidly 
and/or carry multiple resistance to antibiotics. They are the cause of high mortality and possible nosoco-
mial epidemics. For this reason, we implemented microbiological surveillance acquiring samples from pa-
tients with HAI and environmental samples from the surfaces surrounding those patients. A retrospective 
study was carried out from January 2014 to December 2016 in two departments of the University Hospital 
in Messina, Italy: the Microbiology and the Hygiene Laboratories. A comparison was made between the 
microbiological isolates found on the patients and the microorganisms typed further to environmental 
sampling on the surfaces adjacent to the patient with HAI. There was a 24% match in 2014, 22% in 2015 
and 20% in 2016 on total isolates. The most common isolates belonged to the Enterobacteriacae family: 
in particular, an ever-increasing trend has been registered for Klebsiella spp; Acinetobacter baumannii and 
multiresistant Pseudomonas aeruginosa have seen a growing trend for both patient and environmental 
samples. During the three years, the highest infection prevalence rate was found in Anaesthesia and Re-
suscitation, followed by Thoracic and Vascular Surgery.
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The WHO has drawn up a list of the world’s most antibi-
otic-resistant bacteria, with the aim of helping countries 
address national surveillance, research, and development 
activities. Pathogens, prioritised according to the need for 
new antibiotics, were divided into three groups: Priority 
1- Critical (A. baumannii, P. aeruginosa, Enterobacteriace-
ae), Priority 2- High (Enterococcus faecium, S. aureus, He-
licobacter pylori, Campylobacter, Salmonella spp., Neisseria 
gonorrhoeae) Priority 3- Medium (Streptococcus pneumo-
niae, H. influenzae, Shigella spp.) (WHO, 2017).
In European Union countries, E. coli and K. pneumoniae 
have continued to show an increase in third-generation 
cephalosporin resistance percentages, fluoroquinolones 
and aminoglycosides, with phenomena often combined 
to generate multiresistant bacteria. This was aggravated 
by the spread of resistance to carbapenems, especially in 
K. pneumoniae (by 2015 the average percentage of resis-
tant strains was 8.1%). Gram-positive bacteria methicil-
lin-resistant Staphylococcus aureus (MRSA) has been and 
continues to be a public health priority despite its spread 
showing a downward trend, from 18.8% in 2012 to 16.8% 
in 2015 (ECDC, 2015).
In Italy, the spread of multiresistant microorganisms is 
significantly higher than in other European countries. 
This is also attributable to high antibiotic use: the preva-
lence of patients with at least one antibiotic treatment is 
44.0% in Italy, against a European average of 35.0% (range 
21.4 - 54.7%) (Ministry of Health of Italy, 2014).
Surveillance, in line with the guidelines provided by the 
WHO, the CDC and the European Council, is the basis for 
the HAI control activity. Only by implementing this strate-
gy, especially over a prolonged time, can we fully compre-
hend the magnitude of the problem and then choose the 
necessary measures to apply in each local situation. For 
this reason, we implemented microbiological surveillance 
acquiring samples from patients with HAI, environmental 
samples from the surfaces surrounding those patients and 
samples from the hands of the healthcare providers who 
dealt with the patient. The aim of our study was to iden-
tify, in a timely manner, any epidemiologically significant 
bacterial strains that cause diffusion and multi-resistance 
(alert microorganisms), to prevent the epidemics caused 
by such germs by choosing the necessary measures each 
time to help keep HAI under control and to become aware 
of our hospital microbial flora.
METHODS
Our study was conducted from January 2014 to Decem-
ber 2016 in two departments of the University Hospital 
(A.O.U. Policlinico “G. Martino”) in Messina, Italy. The bi-
ological samples of the hospitalised patients were tested in 
the Microbiology Laboratory and the environmental sam-
ples of the surfaces around those patients were analysed in 
the Hospital Hygiene Laboratory.                             
First, pathogens isolated from biological samples taken 
from patients who had developed an infection 48 h after 
hospitalisation were considered, in accordance with the 
criteria of the Centers for Disease Control and Prevention 
(CDC/NHSH, 2013). MDR microorganisms identified ac-
cording to their characteristics and local microbiological 
status are:
 – Staphylococcus aureus resistant to methicillin (MRSA);
 – Carbapenemase producing and/or Colistin-resistant 
Enterobacteriaceae (Enterobacter spp., Klebsiella spp., 
Serratia spp., Escherichia coli, Proteus spp. and other 
Enterobacteria) ESBL;
 – Glycopeptide-resistant Enterococcus faecalis/faecium 
(VRE);
 – Multidrug-resistant Acinetobacter baumannii;
 – Carbapenem and Colistin-resistant Pseudomonas aeru-
ginosa;
 – Clostridium difficile toxin manufacturer A and/or B 
(toxins detection in diarrheal stool specimens).
Samples from the patient were identified and subjected to 
sensitivity tests to different antimicrobials with VITEK® 
2 (Bio-Mérieux, Marcy l’Etoile, France). Multiresistance 
was defined based on the presence of germs resistant to 
three or more classes of antimicrobials including pip-
eracillin (± tazobactam), ceftazidime, fluoroquinolones, 
aminoglycosides and carbapenems (ECDC, 2015). In case 
of positivity, the germ was identified as MDR to the HIC 
(Hospital Infection Committee), the Health Care Depart-
ment and the sample department. The Health Care De-
partment, assessing the need to apply an environmental 
monitoring protocol in a critical or non-critical area, re-
quested microbiological control of the surfaces around 
that patient. Environmental sampling was carried out to 
evaluate the presence of the same MDR germ on the sur-
faces around the patient with HAI. Pre-moistened sterile 
swabs were used at separate collection points based on the 
infectious risk of 10x10 cm2. The areas the samples were 
taken from were: the side and/or lower side of the patient’s 
bed, its bedside table, the crib walls (if a newborn), the hu-
midifier (if used by the patient), the monitor (if a patient 
is admitted, for example, into resuscitation), the drugs 
trolley and the hands of health workers. The swabs were 
taken to the laboratory immediately; they were cultured in 
a brain-heart infusion broth and incubated at 37° for 24-
48 h. Positive samples were prepared for further cultures 
on different growth media: Mannitol salt agar (Oxoid) to 
isolate Staphylococci, MacConkey agar (bioMérieux) to 
isolate Gram negative bacteria and Enterococcosel-agar 
(bioMérieux) to isolate faecal Enterococci. The isolated 
microorganisms were then identified and the resistance 
profile was also evaluated by the same method used for 
patient samples, VITEK® 2 (BioMérieux, France). The out-
come of the tests was then communicated to the Health 
Care Department and the hospital unit involved to imple-
ment immediate containment/isolation measures needed 
to keep HAI under control.
RESULTS
Biological samples from patients with HAI
MDR microorganisms isolated in the years 2014, 2015 and 
2016 were 155, 275 and 49 respectively. The wards from 
which MDR germs were most frequently reported in 2014 
were the wards of Anaesthesia and Resuscitation (22.6%, 
or 35/155 reports), followed by the ward of General Sur-
gery (21.3%, 33/155 reports) and Thoracic and Vascular 
Surgery (14.8%, 23/155). In 2015 most of the reports con-
cerned the ward of Thoracic and Vascular Surgery (19.6%, 
54/275 reports), Anaesthesia and Resuscitation (17.8%, 
49/275) and General Surgery (15.3%, 42/275). In 2016 the 
cases reported in the Anaesthesia and Resuscitation ward 
were 30.6% (15/49 reports), followed by Thoracic and Vas-
cular Surgery (24.5%) and Internal Medicine (14.3%). 
MDR microorganisms most often isolated from clinical 
samples were: in 2014: Acinetobacter baumannii 42.6% 
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Figure 1 - Trend of MDR 
microorganisms isolated 
from patients’ biological 
samples. Trend for each mi-
croorganism isolated from 
the biological samples of 
patients with HAI over the 
course of the three years.
Figure 2 - Trend of envi-
ronmental MDR microor-
ganisms. Trend for each mi-
croorganism isolated on the 
surfaces around the patient 
with HAI over the course of 
the three years.
Figure 3 - Percentage of 
colonized surfaces from 
MDR microorganisms. Per-
centage of positive surfaces 
around the patient with HAI 
following environmental 
sampling.
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(66/155), Klebsiella spp. 23.2% (36/155) and P. aerugino-
sa 14.2% (22/155); In 2015: P. aeruginosa 27.3% (75/275) 
and Klebsiella spp. 23.6% (65/275); In 2016: Klebsiella spp. 
53.1% (26/49) and A. baumannii 24.5% (12/49) (Figure 1). 
In particular, an ever-increasing trend has been registered 
for Klebsiella spp., which has risen from an average of 23% 
in 2014 and 2015 to 53.1% of the isolates in 2016, result-
ing in the most identified germ in the latter year. Multire-
sistant A. baumannii was the most isolated germ in 2014: 
42.6% of clinical samples; then in 2015 it recorded a sharp 
decrease: 13.8% of the isolates, and a subsequent increase 
in 2016 (24.5%). Multiresistant Pseudomonas aeruginosa 
was the most isolated microorganism in 2015, present in 
27.3% of clinical samples, although in 2016 it dropped 
drastically to 2%. As far as MRSA is concerned, it went 
from 4.5% of isolates in 2014 to 2% in 2016.
Environmental samples
MDR microorganisms isolated in the environmental sam-
ples carried out around the patient with HAI in the years 
2014, 2015 and 2016 were 37, 61 and 10 respectively. The 
most isolated germ in 2014 was A. baumannii, 70.3%; in 
2015: P. aeruginosa 29.5% of cases and in 2016 Klebsiella 
spp. in 50%. (Figure 2).
The surfaces that tested positive to environmental sam-
pling are shown in Figure 3. The locations that tested pos-
itive more often were: bedside bars and tables of patients 
infected with MDR germs. The percentage of positives 
found on the hands of healthcare workers was 0% in 2014, 
10% in 2015 and 20% in 2016. A comparison was made 
between the microbiological isolates found on the patients 
and the microorganisms typed further to environmental 
sampling on the surfaces adjacent to the patient with HAI. 
There was a 24% match in 2014 (of which 16.8% was A. 
baumannii), 22% in 2015 (of which 6.5% was P. aerugino-
sa) and 20% in 2016 (of which 10.2% was Klebsiella spp) 
on total isolates.
DISCUSSION
During the three-year period observed, most of the iso-
lated germs on the patient and on the surfaces, in agree-
ment with other studies (Mancini et al., 2016), belonged 
to the Enterobacteriaceae family. We recorded a growing 
trend for Klebsiella pneumonia, which ranged from 23.2% 
to 53.1% in 2014 to 2016 for patient samples and from 
1.9% to 10.2% in 2014 to 2016 of correspondence with 
environmental isolates, in line with recent national and 
European data. (Circular of the Ministry of Health of It-
aly, 2013; Gagliotti et al., 2014; ECDC, 2015). Resistance 
to carbapenems and multiresistance are also common 
for Acinetobacter baumannii and Pseudomonas aerugino-
sa (De Francesco et al., 2013, Boncagni et al., 2015). In 
our study, A. baumannii and multiresistant P. aeruginosa 
showed a growing trend for both patient and environmen-
tal samples. The correspondence between patient samples 
and environmental samples for P. aeruginosa was high-
est in 2015, when a 6.5% match was recorded. Instead, 
this correspondence dropped to 2% in 2016. There was a 
positive result also for A. baumanni, which dropped from 
16.8% in 2014 to 4.1% in 2016, as a consequence of the 
correct and appropriate application of environmental san-
itation procedures.
The decreasing trend for MRSA is in line with what 
emerged from the above-mentioned ECDC report (ECDC, 
2015). There are, by contrast, international studies that 
have reported Acinetobacter spp. and S. aureus as the most 
common pathogens. (Pradhan et al., 2014; Scherbaum et 
al., 2014). Sexton et al. (2006) showed that the MRSA pres-
ent in dust were also found in the breathable air and thus 
the very environment, if not suitably sanitised as we indi-
cated, can be a significant source of contagion.
As for the sampled surfaces, bedside bars and tables 
tested positive more frequently to the presence of MDR 
germs, throughout the observed period of time. In pre-
vious studies we showed the presence of germs, often 
multiresistant, in recovery rooms (La Fauci et al., 2017; 
Squeri et al., 2012). An alarming fact that emerged from 
our research is the microbiological contamination of the 
hands of healthcare professionals by multiresistant germs, 
which increased over the three years observed. This indi-
cates a risk for transmission of infections, demonstrating 
that the proper HAI prevention hand-washing procedures, 
according to WHO guidelines, have not been yet properly 
implemented (WHO, 2009; Squeri et al., 2016), despite the 
continued recommendations to each healthcare worker. A 
reassuring fact that emerged in these three years is the 
decreasing trend of the correspondence between the mi-
crobiological isolates found on patients and the microor-
ganisms typed further to environmental sampling on the 
surfaces adjacent to the patient with HAI, which dropped 
from 24% to 20%. This shows that there has been great-
er attention to our environmental sanitisation procedures 
(through the proper use of disinfectants), despite the lack 
of appropriate handwashing. Given the correspondence of 
multiresistant gram negative bacteria both in the patient 
and the environment in all three years, antibiotic pre-
scription should be based on knowledge of our hospital 
microbial ecosystem and on antibiotic sensitivity profiles 
of bacterial isolates. Hence, a targeted antibiotic therapy 
should be advocated in infection cases. To further reduce 
HAIs, all healthcare workers need to implement the most 
appropriate actions for the various environmental situa-
tions in a timely manner and favour multidisciplinary col-
laboration.
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